Ozone therapy in ophthalmology

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

This review presents an analysis of Russian and international publications on the use of ozone in ophthalmologic diseases, highlighting its pronounced antibacterial and antiviral effects, ability to suppress inflammation, improve local hemodynamics and microcirculation, and normalize impaired blood rheological parameters. A beneficial effect of ozone on metabolic and reparative processes has been established. Course administration of this method was shown to reduce lipid peroxidation activity while simultaneously stimulating the antioxidant system. A positive effect of local ozone therapy techniques has been demonstrated in intraocular infections. Experimental and clinical studies have elucidated the mechanisms of the therapeutic action of ozone in fungal and viral keratitis and in patients with ischemia–reperfusion retinal injury. Ozone has been shown to be an effective therapeutic modality for neurodegenerative disorders at early stages of age-related changes before progression to severe pathology. Ozone therapy for uveitis of various etiologies reduces the time to resolution of choroidal infiltration and the overall duration of treatment. The beneficial role of ozone therapy has been confirmed in high myopia and glaucoma, as well as its successful application in hemophthalmos, particularly in the early period after hemorrhage. Favorable clinical outcomes have been reported with both local and systemic ozone therapy techniques in patients with diabetic retinopathy. The multifactorial mechanisms underlying the therapeutic and preventive effects of ozone, ease of administration, good tolerability, and availability of modern equipment allow for the broad use of this method in ophthalmologic practice.

Full Text

Restricted Access

About the authors

Aleksander G. Kulikov

Burnasyan Federal Medical Biophysical Center

Author for correspondence.
Email: ag-kulikov@mail.ru
ORCID iD: 0000-0002-1408-3308
SPIN-code: 3555-8772

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Moscow

Tatiana N. Velikanova

Krasnov Research Institute Of Eye Diseases

Email: tnw09@mail.ru
ORCID iD: 0009-0006-8032-0777
SPIN-code: 1840-4070
Russian Federation, Moscow

Tatiana S. Kheilo

Center of Therapeutic Ophthalmology

Email: cto96@mail.ru
ORCID iD: 0000-0002-8374-2645
SPIN-code: 8648-6881
Russian Federation, Moscow

References

  1. Alekhina SP, Shcherbatyuk TG. Ozone Therapy: Clinical and Experimental Aspects. Nizhny Novgorod: Litera; 2003. 240 p. (In Russ.)
  2. Bocci V. The case for oxygen-ozonetherapy. Br J Biomed Sci. 2007;64(1):44–9. doi: 10.1080/09674845.2007.11732755
  3. Isxakova RR, Sajfullina FR. Ozone therapy in ophthalmology. Kazan medical journal. 2013;94(4):510–516. EDN: QZIOJH
  4. Scassellati C, Galoforo AC, Bonvicini C, et al. Ozone: a natural bioactive molecule with antioxidant property as potential new strategy in aging and in neurodegenerative disorders. Ageing research reviews. 2020;63:101138. doi: 10.1016/j.arr.2020.101138
  5. Kulikov AG. Ozonotherapy: microhemodynamical aspects. Russian journal of the physical therapy, balneotherapy and rehabilitation. 2012;(3):3–8. EDN: PGPCGF
  6. Borrelli E, Bocci V. Visual improvement following ozonetherapy in dry age related macular degeneration: a review. Med Hypothesis Discov Innov Ophthalmol. 2013;2(2):47–51.
  7. Maslennikov OV, Kontorshchikova KN, Shakhov BE. Manual on Ozone Therapy. 4th ed. Nizhny Novgorod: Istock; 2015. (In Russ.) EDN: WLIOQN
  8. Gulieva MG. The effectiveness of ozone therapy in the treatment of herpetic uveitis. Russian ophthalmological journal. 2017;10(2):23–27. doi: 10.21516/2072-0076-2017-10-2-23-27 EDN: YPIZPR
  9. Egorov AV, Egorov VV, Smolyakova GP, Xudyakov AYu. Analysis of modern possibilities for increasing visual functions after endovitreal surgery of regmatogenous retinal detachment (literature review). Modern technologies in ophthalmology. 2020;(2):97–102. doi: 10.25276/2312-4911-2020-1-97-102 EDN: RCSJHO
  10. Bocci VA. Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res. 2006;37(4):425–35. doi: 10.1016/j.arcmed.2005.08.006
  11. Re L, Mawsouf MN, Menéndez S, et al. Ozone therapy: clinical and basic evidence of its therapeutic potential. Arch Med Res. 2008;39(1):17–26. doi: 10.1016/j.arcmed.2007.07.005
  12. Marchegiani A, Spaterna A. Ozone-based eye drops in anterior segment pathologies: rationale and pre-clinical data. Ozone Therapy. 2017;2(1). doi: 10.4081/ozone.2017.6743
  13. Schulz S, Häussler U, Mandic R, et al. Treatment with ozone/oxygen-pneumoperitoneum results in complete remission of rabbit squamous cell carcinomas. Int J Cancer. 2008;122(10):2360–7. doi: 10.1002/ijc.23382
  14. Borzenok SA, Moroz ZI, Zmyzgova AV. Ozone Therapy in Ophthalmology. A Guide for Doctors. Moscow: State Institution “Microsurgery of the Eye”; 2000. 36 p. (In Russ.)
  15. Copello M, Menéndez S, Hernández F. Ozone Therapy in Retinitis Pigmentosa Patients: Clinical Evolution and Oxidative Stress Behavior in Retinitis Pigmentosa Patients Treated with Ozone Therapy over 20 Years. Ozone: Science & Engineering. 2012;34(6):476–483. doi: 10.1080/01919512.2012.719380
  16. Tumanova AL. Sanatorium resort prevention and rehabilitation of eye disorders. Kurortnaya medicina. 2017;(4):114–117. EDN: XQYGNF
  17. Gundorova RA, Khoroshilova-Maslova IP, Bordyugova GG, Ilatovskaya LV. Experimental substantiation of the expediency of using ozonated physiological solutions in case of intraocular infection. Russian annals of ophthalmology. 1996;112(5):9–11. (In Russ.) EDN: SJWZEV
  18. Lapina IM, Sinelshchikova IV. Ozone therapy in ophthalmology. Bulletin of Ophthalmology. 1998;114(6):51–54. (In Russ.)
  19. Boyarinov GA, Boyarinova LV, Gordetsov AS, et al. Is it possible to treat biofilm bacterial infections with ozone? Biоradicals and antioxidants. 2018;5(3):162–173. (In Russ.) EDN: YLAKRN
  20. Yusupov AA, Yusupova MA, Yusupova NA. Increasing the effectiveness of combined treatment of viral conjunctivitis using ozone gas through glasses. Modern technologies in ophthalmology. 2018;(1):434-436. (In Russ.) EDN: YSLSVK
  21. Yuzhakov AM, Bykov VP, Zurnyaeva ID, Gogodze MD. New Perspectives in the Treatment of Intraocular Infection. Russian annals of ophthalmology. 2000;116(2):20–23. (In Russ.) EDN: QBTWPL
  22. Passidomo F, Pignatelli F, Addabbo G, Costagliola C. Topical Liposomal Ozonated Oil in Complicated Corneal Disease: A Report on Three Clinical Cases. Int Med Case Rep J. 2021;14:327–332. doi: 10.2147/IMCRJ.S311839
  23. Giralt IM, de Los Bueis AB, Ucero AM, Colomo PV. Management of neurotrophic corneal ulcer with a topical liposomal ozonated oil: A report on three clinical cases. Am J Ophthalmol Case Rep. 2025;38:102344. doi: 10.1016/j.ajoc.2025.102344
  24. Spadea L, Tonti E, Spaterna A, Marchegiani A. Use of Ozone-Based Eye Drops: A Series of Cases in Veterinary and Human Spontaneous Ocular Pathologies. Case Rep Ophthalmol. 2018;9(2):287–298. doi: 10.1159/000488846
  25. Pérez-Santonja JJ, Güell JL, Gris O, et.al. Liposomal Ozonated Oil in Ocular Infections: A Review of Preclinical and Clinical Studies, Focusing on Its Antiseptic and Regenerative Properties. Clin Ophthalmol. 2022;16:1953–1962. doi: 10.2147/OPTH.S360929
  26. Benítez-Del-Castillo JM. Liposomal ozonated oil effectiveness in the signs and symptoms of blepharitis in usual clinical practice. Eur J Ophthalmol. 2024;34(3):678–682. doi: 10.1177/11206721231207116
  27. Varol K, Koç AN, Çakır Bayram L, et al. Studies on the Effectiveness of Ozone Therapy on the Treatment of Experimentally Induced Keratitis with Candida albicans in Rabbits. Semin Ophthalmol. 2022;37(2):253–264. doi: 10.1080/08820538.2021.1995006
  28. Bystrov AM, Davydova EV, Kuznetzov AA, Sumina MS. Use of ozone therapy in the treatment of complications following penetrating keratoplasty for rosacea-associated keratitis. Russian annals of ophthalmology. 2025;141(4):66–72. doi: 10.17116/oftalma202514104166 EDN: PEVNBZ
  29. Sabirova DB, Yusupov AA, Iskandarov ShX, et al. Clinical evaluation of ozonotherapy and cryopeksia of patients with herpetic keratitis. Point of view. East — West. 2016;(1):147–149. EDN: WHCODL
  30. Bistrov AM, Davidova YV, Kuznetsov AA. The use of ozone therapy in the complex treatment of corneal transplant rejection reaction. International research journal. 2024;(10):1–6. doi: 10.60797/IRJ.2024.148.22 EDN: HMFBYI
  31. Osborne NN, Casson RJ, Wood JP, et al. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res. 2004;23(1):91–147. doi: 10.1016/j.preteyeres.2003.12.001
  32. Kal A, Kal O, Akillioglu I, et al. The protective effect of prophylactic ozone administration against retinal ischemia-reperfusion injury. Cutaneous and ocular toxicology. 2017;36(1):39–47. doi: 10.3109/15569527.2016.1156120
  33. Gong L, Pasquale LR, Wiggs JL, et.al. Description of a Nonhuman Primate Model of Retinal Ischemia/Reperfusion Injury. Transl Vis Sci Technol. 2023;12(6):14. doi: 10.1167/tvst.12.6.14
  34. Yıldız A, Şehitoğlu MH, Karaboğa İ, Arıkan S. Ozone treatment for high-dose systemic Steroid-Induced retinal injury. Cutaneous and ocular toxicology. 2020;39(3):274–280. doi: 10.1080/15569527.2020.1790590
  35. Kashiwagi K, Saito K, Wang YD, Takahashi H, Ishijima K, Tsukahara S. Safety of ozonated solution as an antiseptic of the ocular surface prior to ophthalmic surgery. Ophthalmologica. 2001;215(5):351–356. doi: 10.1159/000050884
  36. Neroev VV, Zueva MV, Tsapenko IV, Khandzhian AT. The impact made by ozone-therapy on the functional activity of the retina in patients with involutional central chorioretinal dystrophy. Russian annals of ophthalmology. 2003;119(6):18–21. EDN: TUDJXZ
  37. Neroev VV, Sarygina OI, Zueva MV, Tsapenko IV, Egorova EN. Impact of ozone therapy on the electrophysiological parameters of the retina in patients operated on for its rhegmatogenous detachment. Russian annals of ophthalmology. 2007;123(5):33–36. EDN: UIZOSJ
  38. Borrelli E, Diadori A, Zalaffi A, et al. Effects of major ozonatedautohemotherapy in the treatment of dry age related macular degeneration: a randomized controlled clinical study. Int J Ophthalmol. 2012;5(6):708–713. doi: 10.3980/j.issn.2222-3959.2012.06.11
  39. Sаbirova D, Tulikova G, Palvanov Kh, Azimov K. Evaluation of the Effectiveness of Ozone Therapy in Age-Related Macular Degeneration. Bulletin of the Doctor. 2013;1(3):179–180. (In Russ.)
  40. Kulikova MP, Aksenova SV, Neverova EA. Clinical Effectiveness of Ozone Therapy in the Complex Treatment of Patients with Uveitis. Mordovia university bulletin. 2006;16(2):67–72. EDN: TEHXUB
  41. Chernysheva AD. Application of ozone and plasmapheresis in the complex treatment of uveitis. Bulletin of siberian medicine. 2009;8(3):117–120. doi: 10.20538/1682-0363-2009-3-117-120 EDN: KVMYTD
  42. Guliyeva MG. Comparative clinical study the effectiveness of plasmapheresis with ozone therapy in the prevention of ocular herpes recurrence. Oftal`mologiya. 2019;16(1):76–80. doi: 10.18008/1816-5095-2019-1-76-80 EDN: VXHVPZ
  43. Chakieva AR, Gaidamak VV, Bazarbaeva ChS. Evalution of the state of the lipoperoxidation and enzymal antioxidant protection in treatment of high-grade complicated myopia. Vestnik of KSMA named after I.K. Akhunbaev. 2022;(2):163–166. doi: 10.54890/1694-640520222162. EDN: FZJOFC
  44. Lapkina II. Features of the dynamics of interrelations of the indicators of the state of the retina in the process of ozone therapy in the complicated form of myopia. Bulletin of Problems in Biology and Medicine. 2013;2(3):176–180. EDN: RSBQEX
  45. Kurzhupova NS, Baranov VI. Dynamics of Visual Functions in the Application of Ozone Therapy in the Complex Treatment of Patients with Primary Open-Angle Glaucoma. Scientific Bulletin of Belgorod State University. Series: Medicine. Pharmacy. 2014;(11–1):40–44. (In Russ.) EDN: QLGRDX
  46. Nechepurenko OA, Kolesnikova LN, Falhout OS, Fedorov AA, Medvedev IB. Possibilities of ozonoterapy in hemophthalm treatment. Oftal`mologiya. 2010;7(3):26–28. EDN: NCHSJZ
  47. Nechepurenko OA, Kolesnikova LN, Falchut OS, Medvedev IB. New aspects of therapy of hemophthalm caused by hypertension and diabetes mellitus. Oftal`mologiya. 2011;8(2):53–55. EDN: ONDNOH
  48. Kulikov AG, Kiseleva ОM. Physical factors in the treatment of diabetic retinopathy. Russian journal of the physical therapy, balneotherapy and rehabilitation. 2003;(4):25–28. EDN: ONMHPD
  49. Kulikov A, Kiselyeva O. Diabetic retinopathy: physiotherapy resources. Medicinskij vestnik MVD. 2019;(1):55–59. EDN: VSGRDM
  50. Yurova OV, Turova EA, Morozova NE, Nazarova GA, Rogan OA. Treatment and secondary prophylaxis integrated approach at non-proliferative diabetic retinopathy. Oftal`mologiya. 2011;8(3):9–12. EDN: OMSCIP
  51. Borzenok SA, Kulikov AG, Kiseleva OM. Results of the use of ozone in the complex treatment of diabetic retinopathy. Oftal`moxirurgiya. 2003;(4):29–32. EDN: PXQZHD

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2026 Eco-Vector

License URL: https://eco-vector.com/for_authors.php#07

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 86508 от 11.12.2023
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80650 от 15.03.2021
г.